- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07773402
Comparison of Functional Outcome Between Locking Plate Technique Versus Hybrid Ilizarov Technique in Patients With Schatzker Type V and VI Tibial Plateau Fractures (TPF)
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Complex tibial plateau fractures, particularly Schatzker type V and VI fractures, are associated with substantial articular and metaphyseal injury and may present challenges in achieving satisfactory fracture reduction, stable fixation, soft-tissue preservation, and functional recovery.
The present comparative study will be conducted in the Orthopedic Department of Jinnah Hospital, Lahore. A total of 78 patients meeting the eligibility criteria will be recruited. Participants will be assigned to one of two treatment groups: Group A will undergo fixation using the hybrid Ilizarov technique, while Group B will undergo fixation using a locking plate technique.
Patients will undergo clinical and radiological assessment during follow-up. Functional outcome will be assessed using the Rasmussen Knee Functional Score. Radiographs will be obtained at regular follow-up intervals to evaluate fracture healing and union. Postoperative complications, including infection and non-union, will be documented.
The study will compare functional outcomes and fracture-healing outcomes between the two treatment techniques.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Montiha Azeem
- Telefonnummer: 03479717317
- E-Mail: muntahaazeem9@gmail.com
Studieren Sie die Kontaktsicherung
- Name: Sajjad Hussain
- Telefonnummer: 0333 4077389
- E-Mail: prof.sajjadhussain@aimc.edu.pk
Studienorte
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Rekrutierung
- Jinnah Hospital Lahore
-
Kontakt:
- Sajjad Hussain
- Telefonnummer: 0333 4077389
- E-Mail: muntahaazeem9@gmail.com
-
Kontakt:
- Montiha Azeem
- E-Mail: muntahaazeem9@gmail.com
-
Hauptermittler:
- Sajjad Hussain
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Patients of either sex.
- Age between 25 and 50 years.
- Patients presenting within 2 weeks of sustaining the fracture.
- Patients diagnosed with complex tibial plateau fractures classified as Schatzker type V or VI.
- Patients willing to participate in the study.
- Patients providing written informed consent.
Exclusion Criteria:
- Associated ipsilateral limb fractures.
- Pathological fracture of the tibia.
- Associated major organ injuries.
- Psychiatric illness that may interfere with participation or outcome assessment.
- Refusal to provide informed consent.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Hybrid Ilizarov Technique
Patients with Schatzker type V or VI tibial plateau fractures will undergo fracture reduction and fixation using a hybrid Ilizarov external fixation technique.
Closed or minimally open reduction will be performed under C-arm fluoroscopic guidance, followed by application of a hybrid Ilizarov frame using tensioned Kirschner wires and Schanz screws.
Bone graft or bone substitute may be used when clinically indicated.
|
Patients with Schatzker type V or VI tibial plateau fractures will undergo fracture reduction and fixation using a hybrid Ilizarov external fixation system under C-arm fluoroscopic guidance.
Closed or minimally open reduction will be performed as appropriate.
The construct will consist of a hybrid Ilizarov C-ring with appropriately tensioned Kirschner wires and Schanz screws.
Additional wires or fixation components may be used when required to achieve adequate fracture stability and alignment.
Bone graft or bone substitute may be used when clinically indicated.
|
|
Aktiver Komparator: Locking Plate Technique
Patients with Schatzker type V or VI tibial plateau fractures will undergo fracture reduction and internal fixation using a locking compression plate under C-arm fluoroscopic guidance.
Appropriate medial and/or lateral plate fixation will be performed according to fracture configuration and stability.
Bone grafting may be used when clinically indicated.
|
Patients with Schatzker type V or VI tibial plateau fractures will undergo fracture reduction and internal fixation using a locking compression plate under C-arm fluoroscopic guidance.
The appropriate surgical approach and medial and/or lateral plate configuration will be selected according to fracture morphology, comminution, and stability.
Bone graft or bone substitute may be used when clinically indicated.
Postoperative rehabilitation will include early knee range-of-motion exercises, non-weight-bearing ambulation initially, and progressive weight-bearing according to clinical and radiological fracture healing.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Rasmussen Knee Functional Score
Zeitfenster: 8 weeks and 16 weeks
|
Functional outcome will be assessed using the Rasmussen Knee Functional Score at the final postoperative assessment.
Scores will be categorized as excellent (27-30), good (20-26), fair (10-19), or poor (6-9).
The score will be compared between patients treated with hybrid Ilizarov fixation and those treated with locking plate fixation.
|
8 weeks and 16 weeks
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- ERB196/4/06-11-2025/AIMC/JHL
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .